# Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy

> **NCT00610532** · PHASE4 · TERMINATED · sponsor: **Jim McAuley** · enrollment: 8 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** phenytoin
- **DRUG:** phenytoin and probenecid

## Key facts

- **NCT ID:** NCT00610532
- **Lead sponsor:** Jim McAuley
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-03
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Investigators decided not to continue
- **Last updated:** 2013-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610532, "Evaluating the Transporter Protein Inhibitor Probenecid In Patients With Epilepsy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00610532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*